Sidoti Csr Has Optimistic Outlook of USNA Q1 Earnings

USANA Health Sciences, Inc. (NYSE:USNA) – Analysts at Sidoti Csr raised their Q1 2025 EPS estimates for USANA Health Sciences in a research report issued to clients and investors on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will post earnings of $0.84 per share for the quarter, up from their previous forecast of $0.73. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.74 EPS, Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $3.09 EPS and FY2026 earnings at $3.63 EPS.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. The business had revenue of $200.22 million for the quarter, compared to analyst estimates of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same quarter in the prior year, the business earned $0.59 EPS.

A number of other research analysts have also commented on the company. DA Davidson raised USANA Health Sciences to a “hold” rating in a report on Friday, December 20th. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Thursday, December 19th.

USANA Health Sciences Trading Down 2.0 %

Shares of NYSE USNA opened at $35.94 on Friday. The firm has a market cap of $685.02 million, a P/E ratio of 12.70, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. The business’s 50 day moving average is $37.88 and its 200-day moving average is $40.01. USANA Health Sciences has a 1-year low of $31.44 and a 1-year high of $54.81.

Hedge Funds Weigh In On USANA Health Sciences

Several hedge funds and other institutional investors have recently made changes to their positions in the company. American Century Companies Inc. increased its stake in USANA Health Sciences by 12.3% in the second quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock valued at $7,229,000 after acquiring an additional 17,460 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after buying an additional 14,756 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after buying an additional 38,547 shares during the last quarter. Pzena Investment Management LLC boosted its stake in USANA Health Sciences by 24.4% in the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after buying an additional 191,289 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C grew its position in USANA Health Sciences by 297.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock valued at $1,346,000 after acquiring an additional 22,251 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by company insiders.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.